Hepatitis C virus (HCV)-related liver disease is a significant cause of morbidity and mortality
in patients with end-stage renal disease (ESRD) who is treated with dialysis or kidney …

We reviewed the literature regarding the serum levels of the enzymes aspartate
aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase in patients …

Background and Objective. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections
are important causes of morbidity and mortality in maintenance hemodialysis patients …

Abstract Background Hepatitis C virus (HCV) infection is a major comorbidity in patients
receiving hemodialysis. Interferon-based antiviral therapy to eradicate HCV is less effective …

Occult hepatitis C virus (HCV) infection (ie., detectable HCV-RNA in the liver or peripheral
blood mononuclear cells) in the absence of both serum HCV-RNA and anti-HCV antibodies …

Hepatitis C virus (HCV) infection is a major health problem in patients with end‐stage renal
disease (ESRD). The incidence of acute HCV infection during maintenance dialysis is much …

Aim: To evaluate the prevalence of HBV, HCV, HDV and HEV infections in populations with
different categories of risk and the seroprevalence of HBV and HCV infections in subjects …

The clinical use of direct‐acting antivirals (DAAs) for hepatitis C virus (HCV) infection has
dramatically changed management of patients with HCV liver disease since 2014; this is …

Background The prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) and its
associated risk factors among haemodialysis (HD) patients in Gaza strip was investigated …

Hepatitis C virus (HCV) infection is a major health problem with significant clinical and
economic burdens in patients with chronic kidney disease (CKD) stage 4 or 5. Current …